ESSA Pharma Inc. (EPIX) Dividend History

ESSA Pharma Inc. (EPIX) is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for prostate cancer. The company specializes in the research and development of novel drugs targeting androgen receptor signaling pathways to treat advanced prostate cancer, including castration-resistant prostate cancer. Founded with a focus on addressing unmet medical needs, ESSA Pharma aims to advance therapies that can overcome resistance to existing treatments.

Suite 720, Vancouver, A1, V5Z 1K5
Phone: (778) 331-0962
Website: https://www.essapharma.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
August 22, 2025	$1.69	08/25/2025	08/19/2025

Company News

Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution

ESSA Pharma Inc. announced a $80 million return of capital distribution to shareholders as part of its discontinuance and winding-up transaction with XenoTherapeutics, with distribution scheduled for August 22, 2025.

Benzinga
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ESSA Pharma Inc. (NASDAQ: EPIX)

Law firm Monteverde & Associates is investigating the proposed sale of ESSA Pharma to Xeno Acquisition Corp, examining the fairness of the transaction terms for shareholders.

GlobeNewswire Inc.
3 Beginner Penny Stocks Trading Mistakes

Check these strategies out for buying penny stocks right no The post 3 Beginner Penny Stocks Trading Mistakes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: DNA

Page data last updated 09/06/2025 04:51:44 UTC